US Stock MarketDetailed Quotes
SBFM Sunshine Biopharma
- 2.8600
- +0.1300+4.76%
Close Nov 29 13:00 ET
- 2.9800
- +0.1200+4.20%
Post 17:01 ET
5.72MMarket Cap-22P/E (TTM)
2.9100High2.7100Low143.38KVolume2.7700Open2.7300Pre Close401.06KTurnover7.18%Turnover RatioLossP/E (Static)2.00MShares608.000052wk High0.23P/B5.71MFloat Cap2.105652wk Low--Dividend TTM2.00MShs Float125600.0000Historical High--Div YieldTTM7.33%Amplitude2.1050Historical Low2.7970Avg Price1Lot Size
About Sunshine Biopharma Company
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.
Company Profile
SymbolSBFM
Company NameSunshine Biopharma
Listing DateFeb 15, 2022
Founded2006
CEODr. Steve N. Slilaty, PhD
MarketNASDAQ
Employees44
Fiscal Year Ends12-31
Address333 Las Olas Way,CU4 Suite 433
CityFort Lauderdale
ProvinceFlorida
CountryUnited States of America
Zip Code33301
Phone1-945-515-0810
Company Executives
- Name
- Position
- Salary
- Dr. Steve N. Slilaty, PhD
- President and Chairman of the Board; Chief Executive Officer of the Company and Nora Pharma Inc
- 560.00K
- Camille Sebaaly
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 695.00K
- Marc Beaudoin
- Chief Operating Officer
- --
- Dr. Abderrazzak Merzouki, PhD
- Chief Science Officer and Director
- 260.00K
- Malek Chamoun, C.P.A.
- Chief Development Officer
- --
- Dr. Rabi Kiderchah, PhD
- Independent Director
- 80.00K
- Dr. Andrew Keller, PhD
- Independent Director
- 80.00K
- David Natan
- Independent Director
- 80.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data